Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00062790 · ClinicalTrials.gov registry record · Phase 4
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00062790 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 50 participants.
The verdict
NCT00062790, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is being done to determine how much certain hormone levels in the prostate decrease when a patient takes dutasteride 0.5mg daily for 3 months prior to TURP. Male patients at least 50 years old willing to take either dutasteride or a placebo (dummy pill) once daily by mouth for 3 months prior to having a surgery to reduce the size of their prostate. During the surgery, very small pieces of the prostate that are removed will be tested to see how much dihydrotestosterone and testosterone (male hormones) are in the tissue.
Interventions
- DRUG Dutasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00062790
The ClinicalTrials.gov registry entry for NCT00062790 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dutasteride is the first listed.
NCT00062790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00062790 about?
NCT00062790 is a clinical study titled "Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels". This study is being done to determine how much certain hormone levels in the prostate decrease when a patient takes dutasteride 0.5mg daily for 3 months prior to TURP. Male patients at least 50 years old willing to take either dutasteride or a placebo (dummy pill) once daily by mouth for 3 months pr...
What is the current status of trial NCT00062790?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2003-10. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00062790?
The interventions under investigation include: Dutasteride (DRUG).
Who is sponsoring clinical trial NCT00062790?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.